AAAAAA

   
Results: 1-7 |
Results: 7
EVALUATION OF SURROGATE MARKERS AND CLINICAL OUTCOMES IN 2-YEAR FOLLOW-UP OF 86 HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC-PATIENTS
Authors: VALENTINE ME JACKSON CR VAVRO C WILFERT CM MCCLERNON D STCLAIR M KATZ SL MCKINNEY RE
Citation: Me. Valentine et al., EVALUATION OF SURROGATE MARKERS AND CLINICAL OUTCOMES IN 2-YEAR FOLLOW-UP OF 86 HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PEDIATRIC-PATIENTS, The Pediatric infectious disease journal, 17(1), 1998, pp. 18-23
IMMUNOLOGICAL RESPONSES ASSOCIATED WITH 12 WEEKS OF COMBINATION ANTIRETROVIRAL THERAPY CONSISTING OF ZIDOVUDINE, LAMIVUDINE, AND RITONAVIR - RESULTS OF AIDS CLINICAL-TRIALS GROUP PROTOCOL-315
Authors: LEDERMAN MM CONNICK E LANDAY A KURITZKES DR SPRITZLER J STCLAIR M KOTZIN BL FOX L CHIOZZI H LEONARD JM ROUSSEAU F WADE M ROE JD MARTINEZ A KESSLER H
Citation: Mm. Lederman et al., IMMUNOLOGICAL RESPONSES ASSOCIATED WITH 12 WEEKS OF COMBINATION ANTIRETROVIRAL THERAPY CONSISTING OF ZIDOVUDINE, LAMIVUDINE, AND RITONAVIR - RESULTS OF AIDS CLINICAL-TRIALS GROUP PROTOCOL-315, The Journal of infectious diseases, 178(1), 1998, pp. 70-79
RELATIONSHIP BETWEEN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED DEMENTIAAND VIRAL LOAD IN CEREBROSPINAL-FLUID AND BRAIN
Authors: MCARTHUR JC MCCLERNON DR CRONIN MF NANCESPROSON TE SAAH AJ STCLAIR M LANIER ER
Citation: Jc. Mcarthur et al., RELATIONSHIP BETWEEN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED DEMENTIAAND VIRAL LOAD IN CEREBROSPINAL-FLUID AND BRAIN, Annals of neurology, 42(5), 1997, pp. 689-698
CSF HIV RNA - RELATIONSHIP TO HIV-ASSOCIATED NEUROLOGICAL DISEASE
Authors: MCARTHUR JC NANCESPROSON T SELNES OA MCCLERNON D STCLAIR M LANIER R
Citation: Jc. Mcarthur et al., CSF HIV RNA - RELATIONSHIP TO HIV-ASSOCIATED NEUROLOGICAL DISEASE, Neurology, 48(3), 1997, pp. 66004-66004
POLYMER-IODINE INACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: SHIKANI AH STCLAIR M DOMB A
Citation: Ah. Shikani et al., POLYMER-IODINE INACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of the American College of Surgeons, 183(3), 1996, pp. 195-200
VIROLOGICAL AND IMMUNOLOGICAL BENEFITS OF INITIAL COMBINATION THERAPYWITH ZIDOVUDINE AND ZALCITABINE OR DIDANOSINE COMPARED WITH ZIDOVUDINE MONOTHERAPY
Authors: SCHOOLEY RT RAMIREZRONDA C LANGE JMA COOPER DA LAVELLE J LEFKOWITZ L MOORE M LARDER BA STCLAIR M MULDER JW MCKINNIS R PENNINGTON KN HARRIGAN PR KINGHORN I STEEL H ROONEY JF RAY MG KURITZKES D RIVERAVASQUEZ C SANTANA J VANLEEUWEN R BOUCHER C REISS P VEENSTRA J KEET R PIERCE P HAAS D BARNES B LOEWENTHAL M DARCYEVANS C KEMP S KOHLI A MYERS R YEO J EMERY S ROMERO C ANDREWS J HANSON C SHORTINO D PATTISHALL K BARRY D
Citation: Rt. Schooley et al., VIROLOGICAL AND IMMUNOLOGICAL BENEFITS OF INITIAL COMBINATION THERAPYWITH ZIDOVUDINE AND ZALCITABINE OR DIDANOSINE COMPARED WITH ZIDOVUDINE MONOTHERAPY, The Journal of infectious diseases, 173(6), 1996, pp. 1354-1366
PROPHYLACTIC ZALCITABINE AND INTERFERON-ALPHA FOR A LARGE-BORE NEEDLESTICK EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: MILDVAN D BERGE P STARRETT S STCLAIR M SALGO M
Citation: D. Mildvan et al., PROPHYLACTIC ZALCITABINE AND INTERFERON-ALPHA FOR A LARGE-BORE NEEDLESTICK EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of acquired immune deficiency syndromes, 7(4), 1994, pp. 416-417
Risultati: 1-7 |